Similarly, Wang et al. [42] found that berberine promoted SIRT1-mediated deacetylation of CPT1A at the Lys675 site, reducing ubiquitin-dependent degradation of CPT1A and ameliorating NASH. Here, SIRT1 is linked to metabolic dysfunction-associated steatohepatitis.